Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism
Authors
Keywords
-
Journal
ChemMedChem
Volume 11, Issue 10, Pages 1069-1077
Publisher
Wiley
Online
2016-05-03
DOI
10.1002/cmdc.201600079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer
- (2016) Meng Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Glucose conjugated platinum(II) complex: Antitumor superiority to oxaliplatin, combination effect and mechanism of action
- (2015) Hong Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles
- (2015) Khine Myint et al. PLoS One
- Highly water-soluble platinum(ii) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties
- (2013) Pengxing Liu et al. CHEMICAL COMMUNICATIONS
- Oxaliplatin-induced Acute Thrombocytopenia: A Case Report and Review of the Literature
- (2013) Kei Suzuki et al. INTERNAL MEDICINE
- Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
- (2013) J. A. Sprowl et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Calcium channel blockers reduce oxaliplatin-induced acute neuropathy: A retrospective study of 69 male patients receiving modified FOLFOX6 therapy
- (2012) Yoko Tatsushima et al. BIOMEDICINE & PHARMACOTHERAPY
- Synthesis and evaluation of malonate-based inhibitors of phosphosugar-metabolizing enzymes: Class II fructose-1,6-bis-phosphate aldolases, type I phosphomannose isomerase, and phosphoglucose isomerase
- (2012) Stéphanie Desvergnes et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin
- (2012) Isao Ito et al. Clinical and Experimental Nephrology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Quantifying the Electronic Effects of Carbohydrate Hydroxy Groups by Using Aminosugar Models
- (2011) Christian M. Pedersen et al. CHEMISTRY-A EUROPEAN JOURNAL
- Oxaliplatin Transport Mediated by Organic Cation/Carnitine Transporters OCTN1 and OCTN2 in Overexpressing Human Embryonic Kidney 293 Cells and Rat Dorsal Root Ganglion Neurons
- (2011) N. N. Jong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy
- (2011) Y.-H. Lu et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature
- (2010) Marnelli A Bautista et al. Journal of Hematology & Oncology
- Development of High-Throughput Quantitative Assays for Glucose Uptake in Cancer Cell Lines
- (2010) Mohamed Hassanein et al. MOLECULAR IMAGING AND BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation